News Focus
News Focus
icon url

asmarterwookie

08/21/17 10:59 AM

#309314 RE: Protector #309308

I think that I will go with Memorial Sloan Kettering as far as Bavituximab is concerned.



Me too.

Will a bonafide trial result?

As far as the NCCN trials...they are recruiting yet no recruits yet.

wook
icon url

Wernaaa

08/21/17 11:05 AM

#309318 RE: Protector #309308

It isn't "worthless" and Mr. White didn't say that!
icon url

purpledawgs

08/21/17 11:45 AM

#309335 RE: Protector #309308

Have they enrolled a single patient yet? I haven't seen the PR.

PD